chr10-6024237-C-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000417.3(IL2RA):​c.367+7G>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.223 in 1,585,976 control chromosomes in the GnomAD database, including 41,976 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.19 ( 3284 hom., cov: 33)
Exomes 𝑓: 0.23 ( 38692 hom. )

Consequence

IL2RA
NM_000417.3 splice_region, intron

Scores

2
Splicing: ADA: 0.00004377
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6O:1

Conservation

PhyloP100: 0.0900
Variant links:
Genes affected
IL2RA (HGNC:6008): (interleukin 2 receptor subunit alpha) The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. Homodimeric alpha chains (IL2RA) result in low-affinity receptor, while homodimeric beta (IL2RB) chains produce a medium-affinity receptor. Normally an integral-membrane protein, soluble IL2RA has been isolated and determined to result from extracellular proteolyisis. Alternately-spliced IL2RA mRNAs have been isolated, but the significance of each is presently unknown. Mutations in this gene are associated with interleukin 2 receptor alpha deficiency. Patients with severe Coronavirus Disease 2019 (COVID-19), the disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have significantly elevated levels of IL2R in their plasma. Similarly, serum IL-2R levels are found to be elevated in patients with different types of carcinomas. Certain IL2RA and IL2RB gene polymorphisms have been associated with lung cancer risk. [provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 10-6024237-C-G is Benign according to our data. Variant chr10-6024237-C-G is described in ClinVar as [Benign]. Clinvar id is 300259.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.236 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL2RANM_000417.3 linkc.367+7G>C splice_region_variant, intron_variant Intron 3 of 7 ENST00000379959.8 NP_000408.1 P01589
IL2RANM_001308242.2 linkc.367+7G>C splice_region_variant, intron_variant Intron 3 of 6 NP_001295171.1 P01589Q5W005
IL2RANM_001308243.2 linkc.367+7G>C splice_region_variant, intron_variant Intron 3 of 5 NP_001295172.1 P01589H0Y5Z0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL2RAENST00000379959.8 linkc.367+7G>C splice_region_variant, intron_variant Intron 3 of 7 1 NM_000417.3 ENSP00000369293.3 P01589

Frequencies

GnomAD3 genomes
AF:
0.188
AC:
28526
AN:
152094
Hom.:
3278
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0824
Gnomad AMI
AF:
0.260
Gnomad AMR
AF:
0.137
Gnomad ASJ
AF:
0.159
Gnomad EAS
AF:
0.247
Gnomad SAS
AF:
0.239
Gnomad FIN
AF:
0.333
Gnomad MID
AF:
0.152
Gnomad NFE
AF:
0.233
Gnomad OTH
AF:
0.176
GnomAD3 exomes
AF:
0.211
AC:
52998
AN:
251124
Hom.:
6155
AF XY:
0.217
AC XY:
29434
AN XY:
135712
show subpopulations
Gnomad AFR exome
AF:
0.0806
Gnomad AMR exome
AF:
0.115
Gnomad ASJ exome
AF:
0.149
Gnomad EAS exome
AF:
0.249
Gnomad SAS exome
AF:
0.235
Gnomad FIN exome
AF:
0.319
Gnomad NFE exome
AF:
0.231
Gnomad OTH exome
AF:
0.214
GnomAD4 exome
AF:
0.227
AC:
325798
AN:
1433764
Hom.:
38692
Cov.:
28
AF XY:
0.228
AC XY:
163003
AN XY:
715178
show subpopulations
Gnomad4 AFR exome
AF:
0.0752
Gnomad4 AMR exome
AF:
0.117
Gnomad4 ASJ exome
AF:
0.151
Gnomad4 EAS exome
AF:
0.249
Gnomad4 SAS exome
AF:
0.237
Gnomad4 FIN exome
AF:
0.321
Gnomad4 NFE exome
AF:
0.233
Gnomad4 OTH exome
AF:
0.219
GnomAD4 genome
AF:
0.188
AC:
28545
AN:
152212
Hom.:
3284
Cov.:
33
AF XY:
0.191
AC XY:
14226
AN XY:
74394
show subpopulations
Gnomad4 AFR
AF:
0.0825
Gnomad4 AMR
AF:
0.137
Gnomad4 ASJ
AF:
0.159
Gnomad4 EAS
AF:
0.247
Gnomad4 SAS
AF:
0.241
Gnomad4 FIN
AF:
0.333
Gnomad4 NFE
AF:
0.233
Gnomad4 OTH
AF:
0.179
Alfa
AF:
0.186
Hom.:
1002
Bravo
AF:
0.166
Asia WGS
AF:
0.259
AC:
903
AN:
3478
EpiCase
AF:
0.219
EpiControl
AF:
0.216

ClinVar

Significance: Benign
Submissions summary: Benign:6Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Immunodeficiency due to CD25 deficiency Benign:3
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Aug 19, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:2
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 20% of patients studied by a panel of primary immunodeficiencies. Number of patients: 19. Only high quality variants are reported. -

not provided Benign:1Other:1
-
GenomeConnect, ClinGen
Significance: not provided
Review Status: no classification provided
Collection Method: phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
1.2
DANN
Benign
0.70

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000044
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs11256369; hg19: chr10-6066200; COSMIC: COSV56920923; COSMIC: COSV56920923; API